(Q58414485)
Statements
Treatment of patients with low-risk myelodysplastic syndromes using a combination of all-trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor (English)
W K Hofmann
A Ganser
G Seipelt
C Zander
G Geissler
K Hoffmann
K Höffken
J T Fischer
G Isele